البلد: أيرلندا
اللغة: الإنجليزية
المصدر: HPRA (Health Products Regulatory Authority)
Enalapril maleate
Accord Healthcare Ireland Ltd.
C09AA02
Enalapril maleate
Tablet
enalapril
Marketed
2022-02-18
PACKAGE LEAFLET: INFORMATION FOR THE USER ENALAPRIL MALEATE ACCORD 5 MG TABLETS ENALAPRIL MALEATE ACCORD 10 MG TABLETS ENALAPRIL MALEATE ACCORD 20 MG TABLETS READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor, pharmacist or nurse. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. The full name of this medicine is Enalapril maleate Accord 2.5 mg, 5 mg, 10 mg, 20 mg tablets but within this leaflet it will be referred to as Enalapril maleate Accord tablets. WHAT IS IN THIS LEAFLET 1. What Enalapril maleate Accord tablets are and what they are used for 2. What you need to know before you take Enalapril maleate Accord tablets 3. How to take Enalapril maleate Accord tablets 4. Possible side effects 5. How to store Enalapril maleate Accord tablets 6. Contents of the pack and other information 1. WHAT ENALAPRIL MALEATE ACCORD TABLETS ARE AND WHAT THEY ARE USED FOR Enalapril maleate Accord tablets contain an active substance called Enalapril maleate Accord. These belong to the group of medicines called ACE inhibitors (angiotensin converting enzyme inhibitors). Enalapril maleate Accord tablets are used to: treat high blood pressure (hypertension) treat heart failure (weakening of heart function). It can lower the need to go to hospital and can help some patients live longer prevent the signs of heart failure. The signs include shortness of breath, tiredness after light physical activity such as walking, or swelling of the ankles and feet. This medicine works by widening your blood vessels. This lowers your blood pressure. The medicine usually starts to work within an hour اقرأ الوثيقة كاملة
Health Products Regulatory Authority 21 February 2022 CRN009JS6 Page 1 of 14 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Enalapril maleate Accord 10mg tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 10 mg of enalapril maleate Excipient(s) with known effect This medicine contains 57.35-60.49 mg of lactose monohydrate per tablet. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Tablet. Light Pink to Pink coloured, triangular shaped (6.50 mm diameter), biconvex uncoated tablets with mottled appearance, debossed with "IS3" on one side and BREAKLINE on other side. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of Hypertension Treatment of Symptomatic Heart Failure Prevention of Symptomatic Heart Failure in patients with Asymptomatic Left Ventricular Dysfunction (ejection fraction ≤35%) (See section 5.1.) 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology The dose should be individualized according to patient profile (see section 4.4) and blood pressure response. _ _ _Hypertension_ The initial dose is 5 to maximally 20 mg, depending on the degree of hypertension and the condition of the patient (see below). Enalapril maleate Accord is given once daily. In mild hypertension, the recommended initial dose is 5 to 10 mg. Patients with a strongly activated renin-angiotensin-aldosterone system (e.g., renovascular hypertension, salt and/or volume depletion, cardiac decompensation, or severe hypertension) may experience an excessive blood pressure fall following the initial dose. A starting dose of 5 mg or lower is recommended in such patients and the initiation of treatment should take place under medical supervision. Prior treatment with high dose diuretics may result in volume depletion and a risk of hypotension when initiating therapy with enalapril. A starting dose of 5 mg or lower is recommended in such patients. If possible, diureti اقرأ الوثيقة كاملة